Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

Romanian property developer Alezzi Group has completed the transfer of its concrete production operations to Heidelberg Materials Romania, the construction materials producers.
The Galați Court has approved the modified asset recovery plan for Liberty Galați, paving the way for the auction of one of Romania's most important industrial assets to resume.
Nuclearelectrica has completed the first continuous concrete pour for the permanent structures of the Cernavoda Nuclear Power Plant Unit 1 refurbishment project. The operation used approximately 3,470 cubic metres of concrete for the foundation, equivalent to about 380 concrete mixer trucks.
Fondul Proprietatea has exercised its pre-emption right and subscribed to 5.6 million new shares in National Company Administrația Porturilor Maritime (CNAPM), investing €10.8 million to maintain its existing shareholding percentage.
Romania's central bank announced on Friday that annual inflation will rise above previously forecast levels in Q2 2026, but will experience a substantial downward correction in Q3.